Literature DB >> 9972883

Oligodendroglial response to the immune cytokine interferon gamma.

B Popko1, K D Baerwald.   

Abstract

In the human demyelinating disorder multiple sclerosis, and its animal model experimental allergic encephalomyelitis, there is a breakdown of the blood-brain barrier and an infiltration of immune cells into the CNS. Infiltrating T lymphocytes and macrophages are believed to be key mediators of the disease process. Considerable circumstantial and experimental evidence has suggested that the pleiotropic cytokine interferon gamma (IFN-gamma), which is exclusively expressed by T cells and natural killer cells, is a deleterious component of the immune response in these disorders. When experimentally introduced into the CNS IFN-gamma promotes many of the pathological changes that occur in immune-mediated demyelinating disorders. In vitro, this cytokine elicits a number of effects on oligodendrocytes, including cell death. The harmful actions of IFN-gamma on CNS myelin are likely mediated through direct effects on the myelinating cells, as well as through the activation of macrophages and microglia. In this review we summarize relevant studies concerning the action of IFN-gamma in demyelinating disorders and discuss possible mechanisms for the observed effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9972883     DOI: 10.1023/a:1022586726510

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  91 in total

Review 1.  Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development.

Authors:  S L Swain; L M Bradley; M Croft; S Tonkonogy; G Atkins; A D Weinberg; D D Duncan; S M Hedrick; R W Dutton; G Huston
Journal:  Immunol Rev       Date:  1991-10       Impact factor: 12.988

Review 2.  Pathology of the early lesion in multiple sclerosis.

Authors:  J Prineas
Journal:  Hum Pathol       Date:  1975-09       Impact factor: 3.466

3.  Regulation of MHC molecules on MBP positive oligodendrocytes in mice by IFN-gamma and TNF-alpha.

Authors:  A M Turnley; J F Miller; P F Bartlett
Journal:  Neurosci Lett       Date:  1991-02-11       Impact factor: 3.046

4.  Transgenic mouse model for central nervous system demyelination.

Authors:  T Yoshioka; L Feigenbaum; G Jay
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

5.  Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide.

Authors:  D Wong; K Dorovini-Zis
Journal:  J Neuroimmunol       Date:  1992-07       Impact factor: 3.478

Review 6.  Inflammatory mediators in demyelinating disorders of the CNS and PNS.

Authors:  H P Hartung; S Jung; G Stoll; J Zielasek; B Schmidt; J J Archelos; K V Toyka
Journal:  J Neuroimmunol       Date:  1992-10       Impact factor: 3.478

Review 7.  Immunological aspects of demyelinating diseases.

Authors:  R Martin; H F McFarland; D E McFarlin
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

8.  Stoichiometry of interaction between interferon gamma and its receptor.

Authors:  M Fountoulakis; M Zulauf; A Lustig; G Garotta
Journal:  Eur J Biochem       Date:  1992-09-15

Review 9.  Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma.

Authors:  T Olsson
Journal:  J Neuroimmunol       Date:  1992-10       Impact factor: 3.478

Review 10.  Interferons in multiple sclerosis. A review of the evidence.

Authors:  H S Panitch
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

View more
  21 in total

1.  Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process.

Authors:  M Bonora; E De Marchi; S Patergnani; J M Suski; F Celsi; A Bononi; C Giorgi; S Marchi; A Rimessi; J Duszyński; T Pozzan; M R Wieckowski; P Pinton
Journal:  Cell Death Differ       Date:  2014-03-21       Impact factor: 15.828

Review 2.  Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.

Authors:  Yudong Liu; Sara A Gibson; Etty N Benveniste; Hongwei Qin
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

3.  NF-κB Activation Protects Oligodendrocytes against Inflammation.

Authors:  Sarrabeth Stone; Stephanie Jamison; Yuan Yue; Wilaiwan Durose; Ruth Schmidt-Ullrich; Wensheng Lin
Journal:  J Neurosci       Date:  2017-08-23       Impact factor: 6.167

Review 4.  Effector T Cells in Multiple Sclerosis.

Authors:  Belinda J Kaskow; Clare Baecher-Allan
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

Review 5.  The developing oligodendrocyte: key cellular target in brain injury in the premature infant.

Authors:  Joseph J Volpe; Hannah C Kinney; Frances E Jensen; Paul A Rosenberg
Journal:  Int J Dev Neurosci       Date:  2011-03-05       Impact factor: 2.457

Review 6.  eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?

Authors:  Christopher J Carter
Journal:  Schizophr Bull       Date:  2007-02-27       Impact factor: 9.306

7.  Beneficial effect of co-polymer 1 on cytokine production by CD4 T cells in multiple sclerosis.

Authors:  B Fellay; M Chofflon; C Juillard; A M Paunier; T Landis; S Roth; M L Gougeon
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

8.  Deimination restores inner retinal visual function in murine demyelinating disease.

Authors:  Mabel Enriquez-Algeciras; Di Ding; Fabrizio G Mastronardi; Robert E Marc; Vittorio Porciatti; Sanjoy K Bhattacharya
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

9.  PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases.

Authors:  Yifeng Lin; Guangcun Huang; Stephanie Jamison; Jin Li; Heather P Harding; David Ron; Wensheng Lin
Journal:  Am J Pathol       Date:  2013-11-19       Impact factor: 4.307

10.  A direct cross-talk between interferon-gamma and sonic hedgehog signaling that leads to the proliferation of neuronal precursor cells.

Authors:  Li Sun; Zhanzhuang Tian; Jianping Wang
Journal:  Brain Behav Immun       Date:  2009-10-02       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.